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Many cellular Ca2-dependent signaling cascades utilize cal-
modulin (CaM) as the intracellular Ca2 receptor. Ca2/CaM
binds and activates a plethora of enzymes, including CaM
kinases (CaMKs). CaMKK2 is one of the most versatile of the
CaMKs and will phosphorylate and activate CaMKI, CaMKIV,
and AMP-activated protein kinase. Cell expression of CaMKK2
is limited, yet CaMKK2 is involved in regulating many impor-
tant physiological and pathophysiological processes, including
energy balance, adiposity, glucose homeostasis, hematopoiesis,
inflammation, and cancer. Here, we explore known functions of
CaMKK2 and discuss its potential as a target for therapeutic
intervention.
Ca2 is pervasive second messenger that controls many cell
functions by forming a complex with calmodulin (CaM)3 (1),
which serves as a ubiquitous intracellular Ca2 receptor (2).
Upon Ca2 binding, CaM increases its affinity for a large num-
ber of CaM-binding proteins, including three multifunctional
CaM kinases (CaMKI, CaMKII, and CaMKIV) (3). For full acti-
vation, CaMKI and CaMKIV require phosphorylation on an
activation loop Thr by CaMKK or CaMKK (CaMKK1 or
CaMKK2, respectively). The requirement of two CaMKs in the
same signaling pathway led to the concept of a CaMK cascade
(4). In addition to its role in these enzymatic cascades, CaMKK2
is also a physiologically relevant upstream activator of the
AMP-activated protein kinase (AMPK) (5–7), and one role for
this CaMKK2-AMPK complex is the regulation of energy bal-
ance by acting in the hypothalamus (8).
CaMKK2: Structure and Function
CaMKK2 is a 66–68-kDa kinase in rat, mouse, and man
(9–14). Analysis of CaMKK2 cDNA clones revealed a 90%
species similarity in the amino acid coding region but with het-
erogeneity in the 3-noncoding termini (12–14). Similar to
other CaMK family members, CaMKK2 consists of unique N-
and C-terminal domains and a central Ser/Thr-directed kinase
domain that is followed by a regulatory domain composed of
overlapping autoinhibitory and CaM-binding regions (15). The
deduced amino acid sequences of cloned CaMKK2 cDNAs
reveal 30–40% sequence identity of the kinase homology
domain to other members of the CaMK family. However,
CaMKK2 contains a unique 22-residue Pro/Arg/Gly-rich insert
between the ATP-binding and protein substrate motifs (11).
The human CaMKK2 locus spans over 40 kb pairs, maps to
chromosome 12q24.2, and is organized into 18 exons and 17
introns (16). Two major transcripts are generated by use of
polyadenylation sites present in the last two exons. Addition-
ally,CaMKK2 transcripts can be generated by alternative splic-
ing of internal exons 14 and/or 16; this mechanism produces
variants with different roles in neuronal differentiation (16, 17).
PKA and CaMKIV have been reported to be involved in regu-
lation of alternative splicing of the CaMKK2 transcript (17).
Analysis of the sequences of the promoter and 5-untrans-
lated region of the human CaMKK2 gene identified consensus
DNA-binding sequences for several transcription factors,
including Ikaros, RUNX1 (Runt-related transcription factor 1),
and GATA1 (GATA-binding factor 1). The expression of these
transcription factors is typically restricted to stem cell progen-
itors, in which their role is to regulate hematopoiesis and neu-
ropoiesis (19–21). This may be relevant to the fact that
CaMKK2 is expressed in a restricted number of cell types, as
well as the involvement of CaMKK2 in processes regulating
development of neurons and blood progenitors (22, 23).
The most well characterized substrates of CaMKK2 are
CaMKI and CaMKIV. CaMKK2 phosphorylates CaMKIV and
CaMKI on activation loop Thr residues (Thr-200 and Thr-177,
respectively), which increases their kinase activities. Accord-
ingly, mutation of the Thr residue abolishes both phosphoryla-
tion and activation of CaMKI/CaMKIV byCaMKK2 (12).More
recently, AMPK was shown to be an additional substrate of
CaMKK2. Phosphorylation and activation of AMPK occur in
response to an increase in intracellular Ca2 in LKB1 (liver
kinase B1)-deficient cells, and this effect is dependent on
CaMKK2 (5). Down-regulation of CaMKK2 in mammalian
cells using RNA interference almost completely abolishes
AMPK activation (6). Finally, purified CaMKK2 will phosphor-
ylate and activate AMPK in vitro (6), and these two kinases
form a stable multiprotein complex consisting of Ca2/CaM,
CaMKK2, AMPK, and AMPK (8), which is regulated by
Ca2, but not by AMP, due to the absence of the AMP-binding
subunit. Green et al. (24) demonstrated that CaMKK2 and
AMPK associate through their kinase domains and found that
CaMKK2must be in an active conformation to bindAMPK, but
not to associate with other substrates, such as CaMKIV. These
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findings suggest the hypothesis that signals modifying the acti-
vation status of CaMKK2may act asmolecular switches to cou-
ple CaMKK2with AMPK- and/or CaMK-dependent pathways.
The molecular mechanism regulating the enzymatic activity
of CaMKK2 is still not completely defined (Fig. 1). CaMKKs are
autoinhibited by a sequence located immediately C-terminal to
their catalytic domain. This includes overlapping autoinhibi-
tory andCaM-binding regions that are similar to those found in
CaMKI and CaMKIV (11). However, the x-ray structure of
Ca2/CaMbound to this region reveals that the structure of the
bound CaMKK domain is markedly different from those of
other CaMK CaM-binding domains whose structures have
been solved (25). Clearly Ca2/CaM binding causes unique
conformational changes in the CaMKKs relative to other
CaMKs, although the mechanistic reason for this difference
remains to be clarified.
CaMKK2 exhibits significant activity even in the absence of
Ca2/CaM binding (autonomous activity) (12). By using trun-
cation mutants of CaMKK2, a region of 23 amino acids (resi-
dues 129–151) located N-terminal to the catalytic domain was
identified as an important regulatory element of autonomous
activity (26). Mass spectrometry revealed three phosphoryla-
tion sites, Ser-129, Ser-133, and Ser-137 (26, 27), which are
highly conserved in mouse, rat, and human isoforms of
CaMKK2.CaMKK2withmutations of these Ser residues exhib-
its increased autonomous activity but no change in Ca2/CaM-
dependent activity (27). Notably, phosphorylation of Ser-129,
Ser-133, and Ser-137 also increases the stability of CaMKK2.
CDK5 (cyclin-dependent kinase 5) and GSK3 (glycogen syn-
thase kinase 3) have been identified as upstream kinases
responsible for phosphorylating these sites and, in turn, for the
regulation of the autonomous activity of CaMKK2 (27). Fur-
thermore, it has been proposed that a major consequence of
relief from autoinhibition is autophosphorylation of Thr-482, a
post-translational change that likely contributes to the
increased autonomous activity of CaMKK2 (Fig. 1) (28). How-
ever, even though CaMKK2 has autonomous activity against
CaMKI and CaMKIV, substrates that are not regulated by
Ca2/CaM, such as AMPK, still require Ca2/CaM binding to
CaMKK2 to become phosphorylated (7). This helps to explain
the conundrum of why two enzymes in a cascade require the
same allosteric activator. It also suggests that either a Ca2
signal or other non-canonical signaling events could regulate
CaMKK2 activity and serve asmolecular switches to couple this
kinase to several downstream effector pathways.
CaMMK2 Expression in Cells and Tissues
Although CaMKI and CaMKII are ubiquitously expressed,
the expression of other CaMK family members is considerably
more restricted. For example, CaMKIV is expressed at high
levels in testis, aswell as in nervous and immune systems (3, 29).
CaMKK2 is present in many areas of the brain, including the
FIGURE 1.Schematic representationof the structure-activity relationships of CaMKK2.A, CaMKK2 consists of uniqueN- andC-terminal domains (blue and
green, respectively) and a central Ser/Thr-directed kinase domain (red) that is followed by a regulatory domain composed of overlapping autoinhibitory and
CaM-binding regions (Autoreg/CaM, gray). A region of 23 amino acids (residues 129–151) located at theN terminus of the catalytic domain has been identified
as an important regulatory element. CDK5 and GSK3 phosphorylate Ser-129, Ser-133, and Ser-137. PKA phosphorylates Ser-100, Ser-495, and Ser-511. Thr-482
has been identified as an auto/transphosphorylation site. B, although CaMKK2 has autonomous activity for some substrates, binding to Ca2/CaM relieves
autoinhibition, resulting in a fully active kinase. Mutation of Ser-129, Ser-133, and Ser-137 increases autonomous activity with little change in Ca2/CaM-de-
pendent activity. Of note,mutation of Ser-129, Ser-133, and Ser-137 also decreases the stability of CaMKK2. This implies that the autonomously active CaMKK2
generatedbydephosphorylationof these Ser residueswoulddisplay a shorter half-life andbemore rapidly degraded.Mutationof PKA residuesdoesnot affect
CaMKK2 autonomous activity. Phosphorylation of Ser and Thr residues is depicted as blue and red clouds, respectively.
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olfactory bulb, hippocampus, dentate gyrus, amygdala, hypo-
thalamus, and cerebellum (Refs. 12 and 14; see the Gene
Expression Nervous System Atlas (GENSAT) (30)). In addition
to the nervous system, CaMKK2 is present at lower levels in
testis, spleen, and lung (12, 31). In other tissues, such as kidney,
intestine, and heart, the evidence for expression remains less
clear (12, 31, 32).
CaMKK2 can be clearly detected in isolated murine preadi-
pocytes, embryonic fibroblasts, and isolated hepatocytes and in
human umbilical cord vein endothelial cells (32–34). Most
recently, the presence of CaMKK2 in immune cells was exam-
ined and found exclusively in cells of themyeloid linage, includ-
ing bone marrow-derived and freshly isolated peritoneal
macrophages (35).
CaMKK2 and Brain Functions
Calcium controls many neuronal functions, such as neu-
rotransmitter synthesis and secretion and dendritic spine mor-
phology (36). Thus, it is not surprising that proteins involved in
Ca2-dependent pathways, such as CaMKK2, play critical roles
in the development of neurons and brain physiology (37, 38).
Hippocampal Memory—Germ-line ablation of CaMKK2
impairs long-term memory formation (39, 40). The absence of
CaMKK2 is associated with selective loss of long-term potenti-
ation at hippocampal CA1 synapses and with a decrease in spa-
tial training-induced cAMP response-element binding protein
(CREB) activation in the hippocampus (39). However, in con-
trast to CaMKK1/mice, loss of CaMKK2 does not correlate
with deficits in fear conditioning (41).
Initiation and maintenance of synaptic plasticity in CA1
pyramidal neurons of the hippocampus require morphological
changes in dendritic spines, which constitute the main struc-
tural basis for memory formation (42). Studies in cultured neu-
rons revealed requirements for a CaMKK/CaMKI cascade in
regulation of axonal growth cone morphology and outgrowth,
dendritic arborization, and spine and synapse formation (37).
CaMKK and CaMKI co-localize with PIX (p21-activated
kinase-interacting exchange factor) and GIT1 (G-protein-cou-
pled receptor kinase-interacting protein 1) in dendritic spines
as part of a multiprotein complex that regulates actin dynamics
(43). Differential splicing and phosphorylation of critical Ser
residues affect the ability of CaMKK2 to control dendrite/axon
formation (17, 27). Thus, a CaMKK2/CaMKI cascade regulates
learning-induced neuronal cytoskeleton remodeling associated
with memory formation.
Cerebellar Development—Cerebellar granule cells (CGCs)
are the most abundant neurons in the cerebellum. They
develop from granule cell precursors (GCPs), which migrate
from the rhombic lip to form a secondary proliferative zone in
the external granule layer (EGL) (44, 45). During postnatal
development, GCPs in the EGL cease proliferation andmigrate
again to form the internal granule layer, where they make syn-
aptic connections with Purkinje cells. This complex process is
fine-tuned by BDNF, which influences CGC development by
promoting GCP exit from the cell cycle and acting as a chemo-
kinetic factor to induce GCP migration. CaMKK2 is expressed
in the cerebellum, as well as in isolated CGCs (14, 46). Studies
with mouse models revealed that loss of CaMKK2 or its down-
stream target CaMKIV impairs the ability of GCPs to cease
proliferation in the EGL and migrate to the internal granule
layer (23). This phenotype is correlated with decreased CREB
phosphorylation and reduced BDNF expression inGCPs. Thus,
a CaMKK2/CaMKIV/CREB signaling cascade is required for
regulation of BDNFproduction in the postnatal cerebellumand
execution of the program that mediates CGC development
(23).
Hypothalamus—The hypothalamus serves as a center for
integration of hormonal and nutrient signals to modulate food
intake, energy expenditure, and peripheral glucose metabolism
(47, 48). Multiple neuronal populations residing in the hypo-
thalamic arcuate nucleus (ARC) play a critical role in these reg-
ulatory circuits (47, 49). Due to their electrical activity and
release of the orexigenic neuropeptide Y (NPY), NPY/Agouti-
related protein (AgRP) neurons positively regulate feeding
behavior. In contrast, pro-opiomelanocortin neurons inhibit
feeding by releasing the -melanocyte-stimulating hormone.
AgRP neurons inhibit pro-opiomelanocortin neurons and thus
serve amodulatory function to reduce satiety and promote food
intake.
Ghrelin is a hormone produced in the intestine that exerts a
potent central orexigenic effect by acting on hypothalamic
NPY/AgRP neurons via activation of the growth hormone
secretagogue receptor to promote release of NPY (50, 51).
Ghrelin exerts its effects by binding to this Gq-coupled growth
hormone secretagogue receptor, leading to an increase in intra-
cellular Ca2 that is required for transcriptional activation of
the NPY gene, and AMPK has been identified as one relevant
signaling component (52). Accordingly, genetic ablation of
CaMKK2 impairs hypothalamic AMPK activity and down-reg-
ulates NPY and AgRP gene expression in NPY neurons, thus
protectingmice from diet-induced obesity, hyperglycemia, and
insulin resistance (8). Interestingly, because CaMKK2 forms a
complex with AMPK/ and Ca2/CaM, this has been pro-
posed to function as the physiologically relevant signaling com-
plex formediatingCaMKK2-mediated central effects on energy
homeostasis (8).
CaMKK2 is present in themedial hypothalamus, especially in
ventromedial nuclei (8, 14, 53, 54). In these neurons, cell-spe-
cific gene inactivation studies revealed that brain-derived sero-
tonin uses aCaMKcascade involvingCaMKK2 andCaMKIV to
phosphorylate CREB in response to signaling through the
Htr2c serotonin receptor. Thus, CaMKK2 regulates the expres-
sion of genes necessary for optimal sympathetic activity and, in
turn, bone mass accrual, which is negatively correlated with
sympathetic tone (54). Serotonin also acts via its Htr1a and
Htr2b receptors in ARC neurons to favor appetite and decrease
energy expenditure (55).However, to date, neither the nature of
the molecular events elicited by serotonin nor the role of
CaMKK2 in ARC neurons has been explored.
CaMKK2 in Adipose Tissue and Liver
Although CaMKK2/ mice are protected from diet-in-
duced obesity, glucose intolerance, and insulin resistance (8),
they have more adipose tissue thanWTmice when fed regular
chow. Moreover, pair feeding of WT mice to match food con-
sumption of CaMKK2 mice slows weight gain but fails to pro-
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tect from diet-induced glucose intolerance (32). Taken
together, these findings suggested that CaMKK2 may partici-
pate in circuits regulating the metabolic response to overnutri-
tion in peripheral metabolic tissues. Indeed, this idea has been
confirmed by recent studies revealing roles for this kinase in
adipogenesis and hepatic glucose metabolism (32, 33).
Adipogenesis—White adipose tissue (WAT) is an organ
whose major function is to regulate energy homeostasis (56).
Adipocytes differentiate from mesenchymal stem cells in a
complex process known as adipogenesis, which begins in late
gestation and is largely regulated by nutrient availability. In the
adult, there is a general consensus that the number of adi-
pocytes cannot increase by 10% after puberty. Although
CaMKK2 is barely detectable in adult mouse WAT or in iso-
lated adipocytes, this kinase is expressed in preadipocytes (33).
Indeed, genetic ablation of CaMKK2 led to an increase inWAT
mass, which correlated with a decrease in the number of prea-
dipocytes in this tissue. Interestingly, when exposed in vitro to
adipogenic stimuli, primary CaMKK2/ preadipocytes dis-
play a greater ability to differentiate into adipocytes than do
WT cells. Moreover, during the differentiation process of WT
adipocytes, the increase in molecular markers of the mature fat
cell inversely correlates with the disappearance of CaMKK2.
Interestingly, the silencing of AMPK exerts effects compara-
ble to genetic ablation of CAMKK2 by promoting terminal dif-
ferentiation of preadipocytes. Finally, inhibition of the
CaMKK2/AMPK signaling cascade in preadipocytes reduces
Pref-1 (preadipocyte factor 1) and Sox9 (SRY-related HMG
box) mRNA, resulting in accelerated adipogenesis. Thus,
CaMKK2/AMPK functions in the signaling network that reg-
ulates adipocyte development (33).
Hepatic Glucose Metabolism—Although initial reports (11,
12, 31) failed to identify CaMKK2 in liver, this kinase is present
in isolated hepatocytes (32). In fact, acute reduction of hepatic
CaMKK2 reduces blood glucose in mice fed either a regular or
high-fat diet (32). Notably, acute deletion of CaMKK2 in pri-
mary hepatocytes prevents the up-regulation of key enzymes of
the gluconeogenesis pathway, such as glucose-6-phosphate
dehydrogenase and phosphoenolpyruvate carboxykinase, in
response to noradrenaline, an agonist of Ca2 signaling. More-
over, freshly isolated hepatocytes from CaMKK2/mice also
exhibit an increased rate of de novo lipogenesis relative to that
of WT cells. Quiescent and noradrenaline-exposed CaMKK2-
null hepatocytes express less mRNA encoding the PGC-1
(peroxisome proliferator-activated receptor  coactivator 1)
compared with WT hepatocytes, and this defect may be
responsible for impaired glucose-6-phosphatase and phos-
phoenolpyruvate carboxykinase gene expression (32). The
PGC-1 promoter can be activated by the CREB-CREB-bind-
ing protein-TORC2 complex in response to PKA signaling and
repressed by HDAC5 (histone deacetylase 5), a putative target
of CaMKs (57–59). In primary hepatocytes, loss of CaMKK2
prevents phosphorylation of HDAC5 on two residues that are
critical for relief of repression (32). These data inspired the idea
that a CaMKK2/CaMKI signaling cascademay control HDAC5
phosphorylation and, in turn, relief of repression of genes
whose protein products are required for gluconeogenesis (32).
CaMKK2 andMyeloid Cell Physiology
CaMKK2 substrates control important functions in hemato-
poietic and immune cells (29, 60, 61). CaMKIV regulates sur-
vival of activated dendritic cells and the amplitude of the anti-
body response induced by vaccines (62, 63). CaMKI has been
implicated in TLR4 (Toll-like receptor 4) signaling, as well as in
the inflammatory response induced by sepsis (64), and AMPK
plays an important role in the inflammatory response (65).
Together, these findings suggest that CaMKK2 could be
involved in the control of blood cell formation and inflamma-
tory response. Indeed, recent reports identified functions for
CaMKK2 in granulopoiesis andmacrophage activation (22, 35).
Granulopoiesis—The formation of blood cells is a complex
process inwhich hematopoietic stem cells (HSCs) self-renewor
differentiate into more lineage-committed progenitors to ulti-
mately generate all mature blood cells (66). The ability of HSCs
to undergo self-renewal is partly regulated by external signals
originating from the stem cell niche, and a high concentration
of Ca2 at the HSC-enriched endosteal surface provides a
unique microenvironment for stem cells (67, 68). An implica-
tion of these data is that Ca2/CaM-dependent pathways may
play critical roles in hematopoiesis. Supporting this idea,
CaMKIV is involved in regulating HSC survival and mainte-
nance (61).
Most recently, CaMKK2/ mice were found to possess
reduced numbers of HSCs and total bone marrow cells (22).
However, unlike the case for loss of CaMKIV, depletion of
CaMKK2 did not affect the proliferation, survival, or function
of HSCs. Rather, loss of CaMKK2 resulted in marked defects in
early myeloid progenitor populations. Surprisingly, engraft-
ment of CaMKK2-null HSCs by bone marrow transplant led to
an increased repopulation of myeloid cells, and an increased
ability of CaMKK2-null myeloid progenitors to differentiate
into colony-forming unit-granulocytes and Gr1Mac1 gran-
ulocytes was confirmed in vitro. Intriguingly, similar to adi-
pocytes, expression of CaMKK2 inversely correlates with pro-
gression of differentiation, and CaMKK2 mRNA is present in
myeloid progenitors but is undetectable inmature granulocytes
(22). Taken together, the findings on adipogenesis, granulo-
poiesis, and CGCs (22, 23, 33) suggest an intriguing scenario in
which CaMKK2 plays a more general role in progenitor cell
biology, operating as a critical component of the signaling path-
way that regulates proliferation, terminal differentiation, and
commitment of progenitor cells toward a specific lineage.
Macrophages—Macrophages are phagocytes that play an
essential role in clearing the body of debris, apoptotic cells, and
pathogens (69). In lean subjects, macrophages display an atten-
uated inflammatory phenotype and protect adipose tissue from
metabolic stress. Contrariwise, in response to overnutrition,
monocytes recruited to adipose tissue develop into macro-
phages with a proinflammatory phenotype that play a causative
role in the glucose intolerance andmetabolic syndrome associ-
ated with obesity (70). Because macrophages release mediators
that regulate all aspects of host defense, inflammation, and
homeostasis, they play a critical role in the pathogenesis of sep-
sis and many other conditions characterized by an abnormal
response to pathogens and stressing agents (71, 72).
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Genetic ablation of CaMKK2 protects mice from diet-in-
duced obesity, insulin resistance, and glucose intolerance (8).
The ability of CaMKK2 to control food intake in the hypothal-
amus and gluconeogenesis in the liver contributes to this phe-
notype (8, 32). However, obesity is associated with a chronic
inflammatory response that, in turn, causes abnormalities in
glucose metabolism (73, 74). Thus, loss of CaMKK2 could also
exert its effects, at least in part, by mitigating the inflammatory
response to overnutrition, as this would attenuate the detri-
mental effects of chronic inflammation on glucosemetabolism.
Indeed, genetic ablation of CaMKK2 protects mice from the
effects of a high-fat diet by preventing accumulation of macro-
phages and inflammatory cytokines in the adipose tissue of
obesemice (35). Interestingly, CaMKK2-null mice are also pro-
tected from endotoxin shock and fulminant hepatitis induced
by bacterial LPS.
Among blood cell types, CaMKK2 is expressed selectively in
macrophages, and its ablation impairs the ability of macro-
phages to spread, phagocytize bacteria, and release cytokines/
chemokines in response to LPS. This might seem incongruous
because AMPK, a known downstream effector of CaMKK2 in
macrophages, negatively regulates macrophage activation and
polarization and contributes to protection against obesity,
inflammation, and insulin resistance (75–77). However, analy-
sis of events proximal to the TLR4 signaling cascade indicates
that, at early time points, LPS stimulation induces a decrease in
phospho-AMPK, and an increase in phospho-AMPK can be
observed only at later time points (77). Thus, AMPK activa-
tion may not be a direct consequence of TLR4 engagement but
rather mediated by the wave of cytokines released by activated
macrophages, such as IL-10 (77). Taken together, these data are
not compatible with AMPK being a downstream effector of
CaMKK2 in TLR4-mediated signaling.
Actually, loss of macrophage CaMKK2 uncouples TLR4 sig-
naling from the phosphorylation of PYK2/PTK2B (protein
tyrosine kinase 2) and from activation of PYK2 downstream
effectors, such as ERK1/2, NFB, c-Jun, and AKT (35).
CaMKK2may regulate the stability and/or endosome recycling
of PYK2, thus tuning the cross-talk between integrin signaling
and the TLR4-dependent cascade. Thus, in macrophages as
well as in neurons, CaMKK2 participates in signaling pathways
controlling cytoskeleton remodeling and morphological
changes induced by external stimuli (17, 27, 37).
CaMKK2 and Prostate Cancer
The androgen receptor (AR) regulates prostate growth and is
the principal target of therapy aimed at preventing growth and
spreading of androgen-dependent prostate cancer (78). In an
FIGURE 2. CaMKK2 functions as a molecular hub to regulate critical cell functions. CaMKK2 can be activated by signaling through Gq-coupled receptors,
IP3-mediated release of Ca
2 via activation of the IP3 receptor, or Ca
2 entry into cells via plasma membrane ion channels (i.e. voltage-dependent calcium
channel (VDCC)). Calcium signals from integrin and other immunoreceptor tyrosine-based activation motif (ITAM)-coupled immune receptors can activate
IP3-mediated release of Ca
2, activate CaMKK2, and cross-regulate heterologous receptors, such as the Toll-like receptors (TLR). Signaling pathwaysmodulat-
ing GSK3/CDK5 activities can modulate the stability and autonomous activity of CaMKK2. Signals regulating the intracellular level of cAMP can activate
EPAC/PKA-dependent pathways and, in turn, regulate CaMKK2 activity. CaMKI, CaMKIV, and AMPK couple CaMKK2 to multiple downstream cascades, which
conspire to regulate critical cell functions. FcR, Fc receptor; PDE, phosphodiesterase.
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attempt to determine androgen-responsive genes, two groups
recently identified CaMKK2 to be associatedwith prostate can-
cer (79, 80). Frigo et al. (80) revealed that androgens stimulate
the expression of CaMKK2 in androgen-dependent prostate
cancer cells. These authors also identified AMPK as the
downstream effector of CaMKK2 and identified CaMKK2 and
AMPK as components of the signaling pathway downstream of
the AR that mediates prostate cancer cell migration and inva-
sion. Subsequently,Massie et al. (79) used a different strategy to
identify CaMKK2 as a direct AR target, reporting that it is con-
sistently overexpressed in prostate cancer based on analysis of
nine independent clinical gene expression studies. This study
also revealed that the AR directly up-regulated expression of
molecules required for glucose uptake and glycolysis. Pharma-
cological inhibition or siRNA-mediated down-regulation of
CaMKK2 decreased phospho-AMPK, glycolytic flux, glucose
uptake, and lactate and citrate production. Thus, the authors
proposed CaMKK2 to be an important regulator of anabolic
pathways downstream of the AR in prostate cancer cells (79).
Concluding Remarks and Perspectives
CaMKK2 is regulated at many levels bymany signaling path-
ways (Fig. 2). Generation and/or splicing of the primary tran-
script is a regulated event, and in prostate cancer cells, tran-
scription can be regulated by androgens (16, 17, 79, 80).
CaMKK2protein is also subject to numerous post-translational
modifications (Fig. 1) that affect protein stability and activity
(27, 28). The cAMP/PKA pathway can inhibit CaMKK2 activ-
ity, and other inhibitory signals await discovery (81). As
depicted in Fig. 2, CaMKK2 can be activated by signaling
through Gq-coupled receptors, inositol 1,4,5-trisphosphate
(IP3)-mediated release of Ca2 via activation of the IP3 recep-
tor, Ca2 entry into cells via plasma membrane ion channels,
and Toll-like receptors (5, 8, 34, 35). Intriguingly, CaMKK2 can
also be activated by resveratrol, and because this field is still in
its infancy, other stimulatory signals are likely to be discovered
(82). Thus, it may be appropriate to consider CaMKK2 as a
signaling hub that is capable of receiving and decoding signals
transmitted via many diverse cellular regulatory pathways (Fig.
2). Considered in this light, CaMKK2 is one of the most versa-
tile of the multifunctional CaMKs.
The information about CaMKK2 summarized herein sug-
gests that it could be an attractive target for therapeutic inter-
vention in liver and results in improved whole body glucose
homeostasis, at least in part, by changing the primary hepato-
cyte fuel source from glucose to fat (32). In addition, depletion
of CaMKK2 from preadipocytes accelerates their differentia-
tion into adipocytes (33). Finally, among peripheral blood cells,
CaMKK2 is expressed only in those of the myeloid lineage and
controls the activation, cytokine production, phagocytosis, and
motility of macrophages (35). Together, these actions conspire
to render mice resistant to high-fat diet-induced glucose intol-
erance, insulin resistance, and diabetes. Mice deficient in
CaMKK2 fail to accumulate fat when fed a high-fat diet proba-
bly due in part to depletion of the preadipocyte pool during
development and to the inability of macrophages to move into
adipose tissue and produce the proinflammatory cytokines/
chemokines that accelerate diabetes and progression to meta-
bolic syndrome (33, 35). Because, at present, only one small-
molecule inhibitor of CaMKK2 has been reported (83), it might
be prudent to renew the quest to identify potent, highly selec-
tive inhibitors of this versatile protein kinase.
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